Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies

Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: A possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition

(2010) Marianne S. Poruchynsky et al.   CELL CYCLE

Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients

(2010) Roser Velasco et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Mighty mouse

(2009) A. J. Johnson   BLOOD

Induction of angiogenesis by normal and malignant plasma cells

(2009) D. Hose et al.   BLOOD

Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline

(2009) Paul G. Richardson et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bortezomib-induced painful neuropathy in rats: A behavioral, neurophysiological and pathological study in rats

(2009) Cristina Meregalli et al.   EUROPEAN JOURNAL OF PAIN

Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy

(2009) Paul G. Richardson et al.   JOURNAL OF CLINICAL ONCOLOGY

Topical Analgesic Combinations for Bortezomib Neuropathy

(2009) Eric E. Prommer   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy

(2009) Vinay Chaudhry et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity

(2009) Francesca Lanzani et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Bortezomib-induced peripheral neuropathy in multiple myeloma: A comparison between previously treated and untreated patients

(2009) Alessandro Corso et al.   LEUKEMIA RESEARCH

Bortezomib Induces the Formation of Nuclear poly(A) RNA Granules Enriched in Sam68 and PABPN1 in Sensory Ganglia Neurons

(2009) Iñigo Casafont et al.   NEUROTOXICITY RESEARCH

Bortezomib: A novel chemotherapeutic agent for hematologic malignancies

(2008) Kyle N. Utecht et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature

(2008) A. A. Argyriou et al.   BLOOD

Immune-mediated neuropathies in myeloma patients treated with bortezomib

(2008) Sabrina Ravaglia et al.   CLINICAL NEUROPHYSIOLOGY

Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies

(2008) S. Park et al.   CURRENT MEDICINAL CHEMISTRY

Proteasome Inhibition: A Promising Strategy for Treating Cancer, but What About Neurotoxicity?

(2008) A. Gilardini et al.   CURRENT MEDICINAL CHEMISTRY

From Bench to Bedside: A Case of Rapid Reversal of Bortezomib-Induced Neuropathic Pain by the TRPM8 Activator, Menthol

(2008) Leslie A. Colvin et al.   JOURNAL OF CLINICAL ONCOLOGY

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE